Literature DB >> 20133150

Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.

Efthimia Karra1, Ahmed Yousseif, Rachel L Batterham.   

Abstract

Bariatric surgery is the most effective treatment modality for obesity, resulting in durable weight loss and amelioration of obesity-associated comorbidities, particularly type 2 diabetes mellitus (T2DM). Moreover, the metabolic benefits of bariatric surgery occur independently of weight loss. There is increasing evidence that surgically induced alterations in circulating gut hormones mediate these beneficial effects of bariatric surgery. Here, we summarise current knowledge on the effects of different bariatric procedures on circulating gut hormone levels. We also discuss the theories that have been put forward to explain the weight loss and T2DM resolution following bariatric surgery. Understanding the mechanisms mediating these beneficial outcomes of bariatric surgery could result in new non-surgical treatment strategies for obesity and T2DM. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133150     DOI: 10.1016/j.tem.2010.01.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  46 in total

Review 1.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 2.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

3.  Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) Trial: Results at 1 Year.

Authors:  Clifford R Weiss; Godwin O Abiola; Aaron M Fischman; Lawrence J Cheskin; Jay Vairavamurthy; Brian P Holly; Olaguoke Akinwande; Franklin Nwoke; Kalyan Paudel; Stephen Belmustakov; Kelvin Hong; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Richard E Thompson; Taylor Dunklin; Harvey Ziessman; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2019-04-02       Impact factor: 11.105

4.  Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.

Authors:  Clifford R Weiss; Olaguoke Akinwande; Kaylan Paudel; Lawrence J Cheskin; Brian Holly; Kelvin Hong; Aaron M Fischman; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Kristen Kaiser; Amie Park; David M Shade; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2017-02-14       Impact factor: 11.105

5.  Partial small bowel resection with sleeve gastrectomy increases adiponectin levels and improves glucose homeostasis in obese rodents with type 2 diabetes.

Authors:  Gift Kopsombut; Rivka Shoulson; Luca Milone; Judith Korner; Jean-Christophe Lifante; Manu Sebastian; William B Inabnet
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 6.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

7.  Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.

Authors:  Jaime Ruiz-Tovar; Miguel Angel Carbajo; Jose Maria Jimenez; Maria Jose Castro; Gilberto Gonzalez; Javier Ortiz-de-Solorzano; Lorea Zubiaga
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

8.  Impact of Biliopancreatic Limb Length (70 cm vs 120 cm), with Constant 150 cm Alimentary Limb, on Long-Term Weight Loss, Remission of Comorbidities and Supplementation Needs After Roux-En-Y Gastric Bypass: a Prospective Randomized Clinical Trial.

Authors:  Jaime Ruiz-Tovar; Peter Vorwald; Gilberto Gonzalez-Ramirez; María Posada; Gabriel Salcedo; Carolina Llavero; Damian Garcia-Olmo
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

9.  Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.

Authors:  Ana Ramos-Levi; Andres Sanchez-Pernaute; Pilar Matia; Lucio Cabrerizo; Ana Barabash; Carmen Hernandez; Alfonso Calle-Pascual; Antonio Torres; Miguel Rubio
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

10.  Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model.

Authors:  Dong Sun; Shaozhuang Liu; Guangyong Zhang; Punsiri Colonne; Chunxiao Hu; Haifeng Han; Mingxia Li; Sanyuan Hu
Journal:  Surg Endosc       Date:  2013-11-05       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.